MedTrace Logo

Eradication Rates of Helicobacter Pylori and Its Affecting Factors

NCT01922505 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2013-08-14

No results posted yet for this study

Summary

The purpose of this study is to investigate the trend of eradication rates of first-line triple therapy for Helicobacter pylori in recent ten years and clinical factors that affect the eradication in Korean.

Conditions

  • Helicobacter Infections

Interventions

DRUG

PPI triple therapy

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Eligibility

Min Age
16 Years
Max Age
92 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01922505 on ClinicalTrials.gov